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The Center for Health and Homeland Security (CHHS), an affiliated Center of the Law 
& Health Care Program, is celebrating its 15th 
anniversary this year.  What started in response to the 
terrorist attacks of September 11, 2001, has grown 
into a 50+ person legal and policy development 
shop with expertise in all the forms of disaster that 
threaten communities.  At the time CHHS was 
started, Founder and Director Professor Michael 
Greenberger was often questioned on pairing “health” with “homeland 
security,” but the inextricable relationship between the two issues has 
been proven over and over again as the Center has consulted on issues 
from bioterrorism and food safety, to pandemic influenzas, to natural 
disasters such as Hurricane Katrina. These events underscored the critical 
need to include public health and health care stakeholders in security and 
emergency planning of all kinds.
CHHS opened on May 15, 2002 as an initiative by University of Maryland 
Baltimore officials and CHHS Founder and Director Michael Greenberger 
From the Director
I hope you like our new look!  We’ve changed our colors and 
updated our format.  In this issue of the newsletter, we highlight 
two of our affiliated programs and the people who make them run: 
Michael Greenberger and Anita Tarzian.  Professor Greenberger 
is Director of the Center for Health and Homeland Security and 
Dr. Tarzian is the Coordinator of the Maryland Healthcare Ethics 
Network.  These two initiatives, along with the Network for Public 
Health Law, Eastern Region and the Center for Dispute Resolution 
at University of Maryland are a rich source of scholarship and 
collaboration for Law & Health Care Program faculty and students.
Pg 2
The Law & Health Care Newsletter
is published by the Law & Health Care  
Program at the University of Maryland 
 Francis King Carey School of Law 
500 West Baltimore Street 
Baltimore, MD 21201 
L&HCP Faculty
Diane E. Hoffmann, JD, MS 
Director, L&HCP and Professor of Law
Richard Boldt, JD 
Kathleen Hoke, JD 
Sara Gold, JD (visiting) 
I. Michael Greenberger, JD 
Leslie Meltzer Henry, JD, PhD, MSc 
Frank Pasquale, JD, MPhil 
Amanda Pustilnik, JD 
Karen Rothenberg, JD, MPA 
Ellen M. Weber, JD 
Deborah J. Weimer, JD, LLM
Adjunct Faculty 2017-2018
Stephen Carney 
Funk & Bolton, PA
Marc Charmatz, JD 
National Association of the Deaf
James Doherty, Jr., JD 
Pecore & Doherty, LLC
W. Lawrence Fitch, JD 
Maryland Department of Health  
and Mental Hygiene
Marshall E. Jackson, JD 
McDermott Will & Emery
Janet Klein Brown, JD 
Office of the Attorney General
Janet Lord, LLB, LLM  
Syracuse University College of Law
Kathleen McDermott, JD 
Morgan, Lewis & Bockius LLP
M. Natalie McSherry, JD 
Kramon & Graham
Roann Nichols, JD 
Office of the United States Attorney
John S. Nugent, JD 
Office of the Attorney General
Frank Palumbo, PhD, JD 
University of Maryland  
School of Pharmacy
Erik Roskes, MD 
Maryland Department of Health  
and Mental Hygiene
Jack Schwartz, JD 
 
L&HCP Managing Director 
Virginia Rowthorn, JD
MHECN Coordinator 
Anita Tarzian, PhD, RN
to provide policy development and 
legal analysis on homeland security 
issues following the 2001 attacks.  
The scope of work of the Center soon 
expanded and, by summer 2003, the 
Maryland Emergency Management 
Agency asked CHHS to develop 
a manual to guide Maryland state 
agencies through the Continuity of 
Operations (COOP) plan writing 
process in the case of any major 
disaster. Next, Howard County, MD, 
the Baltimore City Health Department, 
and the University of Maryland 
Medical Center tapped CHHS for its 
expertise in emergency planning.  The 
rest, as they say, is history.
The Center now works with over 
25 local, state and federal agencies 
to provide them with expertise 
and training in the areas of crisis 
management and cybersecurity.  The 
Center also provides jobs for many 
law school graduates and externships 
for current law students.  In addition 
to directing the Center and working 
extensively in homeland security 
and counterterrorism law, Professor 
Greenberger created and taught a 
popular seminar at the law school on 
the Law and Policy of Emergency 
Public Health Response. He also 
oversees the recently-created Masters 
of Science in Law’s Homeland 
Security and Crisis Management 
track. This nascent graduate program 
is attracting individuals from both 
the public and private sectors who 
wish to learn about the law of crisis 
management and cybersecurity so that 
they can be more effective in their 
current jobs or move into a career in 
this hot new area.
Greenberger’s expertise in public 
health emergency law is sought out, 
and he has appeared extensively as 
a presenter at national conferences, 
speaking on all matters of public 
health topics, from the need to re-
evaluate quarantine and isolation 
statutes in light of modern 
realities, to using legislative and 
policy approaches to manage the 
governmental response to epidemics. 
He continues to be at the forefront 
of emerging public health issues, 
including the recently-declared 
emergency for opioid addiction in 
Maryland, the impact of civil unrest 
and gun safety on public health, and 
issues arising from novel emerging 
infectious and vector borne diseases, 
such as the Zika virus.
Since the Center opened, Professor 
Greenberger’s health and public 
health work has focused on providing 
clients with extensive legal expertise 
on the public health emergency legal 
landscape.  For example, he might 
be asked by a county government 
who can implement quarantine and 
isolation in the event of a severe 
pandemic influenza; whether the 
Governor of Maryland has the power 
to close schools or public offices 
in a natural disaster; in the event 
of a bioterrorist attack, what legal 
protections are in place for citizens 
who are subject to quarantine orders?  
After answering questions like 
these over several years for multiple 
governmental entities, Greenberger 
and CHHS embarked on one of the 
Center’s hallmark projects, the Public 
Health Emergency Preparedness Legal 
Handbook. Originally drafted in 2010, 
the handbook outlines key issues, 
laws, and regulations relevant to 
emergency public health preparedness 
and response, with specific focus on 
state and federal laws and regulations 
pertaining to a catastrophic health 
emergency. The handbook was one 
of the first of its kind nationally, 
and became the benchmark for such 
U.S. News and World Report ranked 
Maryland Carey Law’s Health Law 
Program #2 in the country for 2017!
  #2
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CHHS Senior Law and Policy Analyst Eric Oddo, delivering a tabletop exercise
guides. Since that time, Maryland 
and the U.S. have learned 
important lessons in public health 
from responding to pandemic 
influenzas, Ebola, and the Zika 
virus. Now, CHHS is working 
with the Maryland Department 
of Health and Mental Hygiene to 
update the handbook with the legal 
and policy developments that have 
occurred since 2010, including 
changes to Maryland law as well 
as to federal regulations. These 
laws include changes to emergency 
preparedness requirements for 
health care facilities that accept 
Medicare and Medicaid patients, 
and federal quarantine and 
isolation regulations.
The legal landscape for public 
health emergencies doesn’t just 
affect public health or health care 
workers, however.  The recent Ebola 
outbreak highlighted the interplay 
between an infectious disease outbreak 
and government agencies that are 
not typically associated with health 
and health care.  When Ebola first 
occurred in the U.S. during the 2014-
2016 epidemic, one of the first clients 
to call CHHS with questions was a 
state transportation agency.  While the 
number of cases of Ebola in the U.S. 
was very few, the limited exposures 
identified  a number of  potential 
preparedness gaps, particularly for 
those in the transportation sector.  
The National Academies of Science 
Transportation Research Board (TRB) 
contracted with CHHS to determine 
whether transit agencies were prepared 
for an infectious disease outbreak and 
whether they had adequate procedures 
in place that take into account legal 
obligations that may affect transit 
stakeholders’ ability to operate or 
respond in a public health crisis.  
After an intensive, year-long legal 
research project, CHHS prepared the 
report: Public Transit Emergency 
Preparedness against Ebola and Other 
Infectious Diseases: Legal Issues.
The TRB report includes extensive, 
nation-wide research and analysis of 
the transportation and public health 
emergency legal landscape, including 
federal transportation and public 
health laws, regulations, statutes, 
and agency policy guidance. CHHS 
also conducted an extensive, 50-state 
survey of public health emergency 
laws to include in the report. CHHS 
staff personally contacted and 
surveyed 250 transit agencies across 
the country about their public health 
emergency protocols and procedures. 
The report, available this spring 
through the Transportation Research 
Board’s website, underscores the 
importance of Professor Greenberger’s 
work through the Center in providing 
public health legal expertise across 
various sectors of government.
A signature service of Professor 
Greenberger and the Center includes 
taking its extensive public health 
emergency knowledge and applying it 
in planning efforts for state, local, and 
regional agencies—be it emergency 
management agencies, public health 
departments, hospitals, or regional 
“What makes the work of the Center so great is that 
it is truly an interprofessional 
collaboration. We have on 
our staff JDs with Health 
Law certificates and MPHs; 
and we work with our highly 
regarded Maryland health law 
faculty, as well as the medical 
school faculty, the Center for 
Vaccine Development, and 
the Cowley Shock Trauma 
Center—to ensure the most 
comprehensive breadth of 
work possible.”
 - CHHS Founder and Director Professor Michael Greenberger
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health coalitions. In the past year 
alone, the Center has created a number 
of plans for clients, some of which 
include:
Communications
When a health emergency occurs, the 
ability of stakeholders to effectively 
communicate and share relevant 
information is critical. CHHS created 
a Communications and Information 
Sharing Plan for a regional health 
coalition, which details how members 
will communicate during regional 
events, and includes a detailed 
discussion of the various available 
communications mechanisms.
Maryland Carey Law School-based Center for Health and Homeland Security Staff 2017
Evacuation
The ability of hospitals and other 
health care facilities to quickly and 
safely evacuate patients is critical 
during emergencies—a lesson 
highlighted by Hurricane Katrina and 
Superstorm Sandy. CHHS worked 
closely with Johns Hopkins Hospital 
to update its hospital evacuation 
policies and to create an easy-to-
read guide and flowchart for hospital 
personnel to use, which was in turn 
used to improve a regional coalition’s 
evacuation guidance for hospitals and 
to help coordinate regional evacuation 
planning. 
Emerging Infectious Disease
The U.S. experience with Ebola 
highlighted a number of challenges 
emerging infectious diseases (EIDs) 
pose for the U.S. health care system 
and public health workers. In light of 
lessons learned, local county health 
systems across the country began 
re-evaluating emergency plans, and 
many realized that new or novel EIDs 
may require protocols and policies not 
typically relied on, such as quarantine 
and isolation, or widespread contact 
tracing. To comprehensively address 
these kinds of concerns, two counties 
requested CHHS’ help in creating 
“Emerging Infectious Disease Plans” 
Law & Health Care Program
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(EIDPs). CHHS staffers worked 
with each county’s public health 
stakeholders to provide planning and 
drafting assistance for their EIDPs. 
Each plan was designed to serve as a 
flexible, scalable, adaptable resource 
for those individuals and teams 
working to respond to the effects of 
an EID in the county. CHHS worked 
with stakeholders to identify planning 
barriers and considerations unique to 
emerging infectious disease response. 
Much of the Center’s work, focuses 
on “boots on the ground” public health 
response. 
For example, in summer and fall of 
2016, the U.S. raced to address the 
emerging Zika virus outbreak, after 
locally-acquired cases were reported 
in Florida and Texas. The response to 
this virus, which is vector-borne but 
also sexually-transmittable, highlights 
how health and public health 
preparedness and response can cut 
across many sectors as public health 
officials worked with environmental 
health workers and public works 
to respond with plans that took 
into account communication and 
outreach, vector testing, and spraying 
and vector control. CHHS staffers 
working in emergency preparedness 
and public health offices played 
critical roles in the Zika response, 
coordinating communication and 
outreach with specific populations, 
such as pregnant women, and 
working with environmental and 
public works agencies to coordinate 
testing and spraying in affected 
areas. Center staffers also provided 
expertise through written analysis, and 
coordinated with key public health 
officials, like Baltimore City Health 
Commissioner Leana Wen, to make 
informational video blogs available. 
As summer draws near, efforts to quell 
the spread of Zika  are again ramping 
up, and Professor Greenberger and 
CHHS staff are prepared.
RECENT PRESENTATIONS AND PUBLICATIONS FROM 
PROFESSOR GREENBERGER AND CHHS STAFF
Michael Greenberger, Presenter and Panelist, Confronting Legal Health Challenges in 
Disadvantaged Communities (speaking on legal approaches to the opioid epidemic), Public 
Health Law Conference, Washington, D.C., September 16, 2016.
Michael Greenberger, Presenter and Panelist, Zika Global to Local: Addressing the Epidemic 
from an International and Interprofessional Lens (speaking on Maryland public health 
emergency laws and local response efforts), University of Maryland, Baltimore, Maryland, 
Global Health Symposium, February 15, 2017.
 
Trudy Henson, Presenter, Public Health Legal Issues in Transportation—Current Trends, 
Transportation Research Board Annual Legal Workshop, Washington, D.C., July 2016.
 
Christine Gentry and Ray Shin, Continuity of Operations Planning During a Public Health 
Emergency: Resource and Volunteer Management, 2016 Public Health Preparedness 
Summit, Dallas, Texas, 2016. 
Preeti Emrick and Christine Gentry, Ebola Virus Disease: International Perspective, Disaster 




Professor Diane Hoffmann is continuing work on her 
NIAID-funded project, Microbiota 
Transplantation: Recommendations 
for a Regulatory Framework, for a 
third year with an extension to April 
2018.  The purpose of the project is to 
study the legal and regulatory aspects 
of microbiota transplantation (MT).  
The most common kind of MT is fecal 
microbiota transplantation (FMT) which 
the FDA currently allows as a treatment 
for refractory Clostridium difficile 
infection (CDI), a serious diarrheal 
disease.
Hoffmann and co-investigators from 
the University of Maryland Schools of 
Law, Pharmacy and Medicine hosted 
the third meeting of the working group 
convened under the grant on December 
12-13, 2016.  The working group is 
composed of approximately 30 experts 
and stakeholders including scientists, 
clinicians, patient and professional 
association advocates, bioethicists, 
academics, lawyers, and individuals 
from the biotechnology industries 
who have an interest in microbiota 
transplantation or expertise relevant to 
the project.  In addition, representatives 
of FDA and NIH were invited to 
participate in the working group as 
observers.  Information about the 
project is available on the project 
website. 
In March 2017, Hoffmann and her 
co-investigators published the first 
article stemming from the project 
in the journal Gut Microbes.  The 
article, “A proposed definition 
of microbiota transplantation for 
regulatory purposes,” notes that there 
is currently no regulatory definition of 
MT or FMT, and the broad range of 
stool and stool-based products being 
used, or under development, to treat 
patients calls for the establishment of 
a definition to help determine which 
among them should be “labeled” FMT. 
The paper focused on FMT but the 
proposed definition was developed 
to cover other types of MTs being 
contemplated, including vaginal, skin, 
nares, and oral.  The investigators 
are currently working on a paper that 
sets forth a three track regulatory 
framework for FMT.
As an outgrowth of the project, 
Professor Hoffmann was asked by 
working group member Dr. Gary Wu 
to join the Strategic Advisory Board 
for the American Gastroenterological 
Association Center for Gut 
Microbiome Research and Education, 
of which Dr. Wu is a member.  In 
addition, project investigators 
Hoffmann and Frank Palumbo, a 
faculty member at the University 
of Maryland School of Pharmacy, 
and working group member Colleen 
Kelly, a gastroenterologist and faculty 
member at Brown University Alpert 
School of Medicine, are speaking 
on June 6 at the upcoming ELSI 
Congress on “Genomics and Society” 
co-sponsored by Columbia Medical 
Center, UConn Health and the Jackson 
Laboratory.   The team will share 
the legal issues raised by microbiota 
transplantation and case studies 
discussed at working group meetings. 
Hoffmann and the other investigators 
are planning a final meeting of the 
working group in early 2018 to finalize 
discussion and recommendations to 
present to NIH and the FDA.
Law & Health Care Program
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On February 26, Law & Health Care Program professor Frank Pasquale spoke as an invited 
guest at a unique panel discussion in Tokyo, Japan to 
explore the challenges and opportunities created by 
new frontiers of human and artificial intelligence.  The 
event was organized by Nobel Media, part of the Nobel 
Foundation, as part of its mission to spread knowledge 
about Nobel Prize-winning achievements and to 
stimulate interest in science, literature and peace across 
the globe.  The conference brought together key opinion 
leaders, policy makers, students, and researchers, 
including Nobel Laureates Jean-Pierre Sauvage (Nobel 
Prize in Chemistry 2016), Edvard I. Moser (Nobel Prize 
in Physiology or Medicine 2014), Eric S. Maskin (Prize 
in Economic Sciences 2007), George F. Smoot (Nobel 
Prize in Physics 2006), and Susumu Tonegawa (Nobel 
Prize in Physiology or Medicine 1987).  Organizers asked speakers to think about such questions as: What will the future 
of intelligence be? What challenges do our societies face from science and technology? What sorts of intelligence do we 
need to meet future challenges?
The event can be viewed at this Youtube link: https://www.youtube.com/nobeldialogue.
Pasquale was on a panel with Dr. Moser titled “Challenges of Science and Technology.”  In his comments, Pasquale 
talked about his article, “The Algorithmic Self,” which explored the psychological and social consequences of algorithmic 
assessments of health, employment, and popularity.  Pasquale’s invitation to this prestigious event stems from his 
scholarship about the challenges posed to information law by rapidly changing technology, particularly in the health care, 
internet, and finance industries. He is a member of the NSF-funded Council for Big Data, Ethics, and Society, and an 
Affiliate Fellow of Yale Law School’s Information Society Project.  He frequently presents on the ethical, legal, and social 
implications of information technology for attorneys, physicians, and other health professionals. His book The Black 
Box SocieTy: The SecreT algoriThmS ThaT conTrol money and informaTion (Harvard University Press, 2015) develops 
a social theory regarding how computational intelligence has come to dominate three important parts of American life: 
reputation, search, and finance.
Frank Pasquale Speaks at “Nobel Prize 
Dialogue Tokyo 2017: The Future of 
Intelligence”
Professor Frank Pasquale (second from left)
A few days after the Nobel Event, Pasquale also 
led a workshop at Taiwan’s Academia Sinica, one 
of the leading research institutions in Asia, on 
predictive analytics and big data in learning health 
care systems. Pasquale met with some of the 
leading privacy and big data analysts in Taiwan, 
in an event that convened attorneys, academics, 
computer scientists, and social scientists. He also 
presented a preview of his current book project, 
Laws of Robotics, at National Taiwan University’s 
law school, focusing on the legal questions raised 
by medical automation and robotics.
Professor Pasquale (center) with participants in Taiwanese workshop
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Profile . . . Dr. Anita Tarzian, Nurse, 
Bioethicist, Critical Member of the  
Law & Health Care Program
One of the lesser known, but possibly most unique, 
components of Maryland Carey 
Law’s health law program is 
the Maryland Healthcare Ethics 
Committee Network (MHECN), 
a membership organization 
designed to support and provide 
educational resources to ethics 
committees serving health 
care institutions in the state of 
Maryland.  This critical resource 
for ethics committees was the 
brainchild of Law & Health 
Care Program (L&HCP) director 
Diane Hoffmann who started 
the Network in 1992 to address 
a gap in resources available to 
ethics committees.  Dr. Tarzian 
is now the program coordinator 
for the network and takes the lead 
role in what has become a robust 
network of ethics committees, 
bioethicists, health care 
providers, and others interested 
in bioethics.  Dr. Tarzian is well 
known in the field of bioethics 
and a treasure in the L&HCP.
Tarzian began work as a tertiary 
care nurse in Chicago in 1986.  
She worked in a surgical 
oncology unit of a large academic 
medical center.  This position 
introduced Tarzian to end-of-life 
situations that presented complex 
ethical questions that had to be 
answered by the medical team 
and families with no ethics 
committee to provide support and 
expertise.  
In 1990, Tarzian joined the 
Peace Corps and served for two 
years in the Dominican Republic 
(DR).  In the DR, Tarzian observed 
another way of dealing with death and 
dying and how that process looks in a 
country with fewer medical resources.  
Tarzian felt there had to be a better 
way to move patients compassionately 
through medical crises and through the 
dying process, particularly in countries 
like the U.S. where high-tech medical 
interventions and burgeoning specialty 
services challenged the humanistic 
nature of how health care is delivered.  
After serving in the Peace Corps, she 
enrolled at the University of Maryland 
School of Nursing (which is part of 
the UMB downtown campus, across 
the street from the law school).  At the 
time, the nursing school offered an MS 
in Intercultural Nursing, which was a 
perfect landing spot for Tarzian after 
serving in the Peace Corps.  Tarzian 
completed a combined M.S.-Ph.D. 
program with a concentration in ethics. 
She was named the Outstanding 
Doctoral Graduate of her graduating 
class.  
During her PhD studies, Tarzian 
worked as a hospice nurse in home-
based and inpatient settings.  This 
experience allowed her to understand 
patients’ needs and desires in the 
dying process, and how to support the 
loved ones of patients at the end of 
life.  Also while getting her graduate 
degrees, Tarzian took a class offered 
by Professor Diane Hoffmann at the 
law school, called Critical issues in 
Health Care. The course was open to 
all professional students on the UMB 
Campus, i.e., law, medical, nursing, 
social work, dentistry and social work. 
Tarzian was a star in the class. 
A few years later, in 1998, Hoffmann, 
a nationally recognized expert in 
medical decision making at the end 
of life, received funding from the 
Greenwall Foundation to evaluate 
competencies of individuals 
conducting ethics consults.  She asked 
Anita to work with her on this project. 
The two have been collaborating 
closely ever since and jointly running 
MHECN.  In addition to preparing the 
MHECN newsletter and responding 
to questions from network members, 
Tarzian organizes annual workshops 
for network members and others.  The 
topics are wide-ranging and include 
Challenges in Organ Donation and 
Transplantation, Religious, Medical, 
Ethical and Legal Perspectives on 
End of Life Issues, and Ethical and 
Legal Issues in Dementia: Navigating 
Difficult Decisions.
Hoffmann and Tarzian also work on 
research projects together on topics 
critical to ethics committees and 
end-of-life care advocacy.  Most 
recently, MHECN received funding 
Professor Anita Tarzian
Law & Health Care Program
Spring Newsletter 2017 Pg 9 
from the Maryland Department of 
Health and Mental Hygiene to evaluate 
the Maryland Medical Orders for 
Life-Sustaining Treatment (MOLST) 
program. This study evaluated how 
MOLST forms are being used and what 
impact the MOLST program has had 
on end-of-life care for Marylanders 
since the MOLST program went into 
effect statewide in 2011. A manuscript 
summarizing the study’s results 
(co-authored by law student Nadia 
Cheevers) has been accepted for 
publication in the Journal of Palliative 
Medicine. 
In addition to coordinating MHECN, 
Tarzian is also an Associate Professor 
at the University of Maryland School 
of Nursing where she teaches a course 
in end-of-life care and a research 
course. She also co-teaches the course 
Death and Dying: Ethical and Legal 
Considerations for a Thanatology 
Certificate Program offered through 
the University of Maryland Graduate 
School. Tarzian is also an IRB Co-
Chair and Human Subjects Protection 
Consultant at Chesapeake Research 
Review, Inc. in Columbia, Maryland.
Although a nurse, Tarzian has been very 
happy with her role at the law school 
and faculty and staff with the Law & 
Health Care Program have enjoyed 
working with her. Coincidentally, 
Tarzian serves on the Maryland 
Judicial Ethics Committee which 
provides guidance to Maryland’s 
judicial officials regarding professional 
ethics. Having worked with lawyers 
for many years in different capacities, 
Tarzian is very familiar with the law 
surrounding medical-decision making 
and finds that she has a different 
understanding of the role of lawyers in 
bioethics than many of her colleagues.  
There is an impression among some 
in the bioethics field that lawyers 
should not be included in the work of 
the ethics committee because they are 
seen primarily as hospital counsel and 
too focused on providing legal advice 
rather than providing ethics advice 
and support when making patient-
centered decisions.  However, that 
is not Tarzian’s experience.  She has 
valued the critical input lawyers make 
to aligning the decisions of ethics 
committees to the structure of the law 
and their ability to be creative problem 
solvers in a complex regulatory area.  
Her long-time association with the law 
school has left her with a very positive 
impression of lawyers in the field.  
She is proud of this “biased” view of 
the legal profession, and is happy to 
be part of the L&HCP.  One memory 
that stands out is learning about the 
SCOTUS (Supreme Court of the 
United States) Blog and following the 
live feed with law school colleagues 
when the Supreme Court was deciding 
the constitutionality of the Affordable 
Care Act's individual mandate.  A 
moment she recalls as “priceless.”  
In addition to her work with 
MHECN, Tarzian is a member of 
the Living Legacy Foundation’s 
Ethics Committee, the University of 
Maryland Medical Center’s Ethical 
Advisory Board, and the American 
Thoracic Society’s Unrepresented 
Patients Working Group. She has 
served on various task forces and 
committees of the American Society 
for Bioethics & Humanities, which 
awarded her a Distinguished Service 
Award in 2011. This Spring, she will 
serve as “Ethicist in Residence” at her 
alma mater, Knox College.
In the future she dreams of MHECN 
forming an ethics consortium 
comprised of members from various 
health care ethics committees and 
trainees who would meet virtually to 
discuss de-identified cases and share 
insights and best practices. Even more 
ambitious is her goal of moving the 
compassionate, informed decision-
making process that ethics committee 
members undertake into the realm 
of everyday life.  Honing skills and 
knowledge among citizens to resolve 
values conflicts more broadly is not a 
bad goal in these tumultuous times.
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Studying the Zika Pandemic from 
Global and Local Perspectives
On February 15, the Law & Health Care Program 
(L&HCP) and the University 
of Maryland Baltimore Center 
for Global Education Initiatives 
held a campus-wide symposium 
during which legal and medical 
experts from the U.S. and Costa 
Rica described the many faces 
of the emerging Zika virus.  The 
symposium, “Zika Global to 
Local: Addressing the Epidemic 
from an International and 
Interprofessional Lens,” looked 
at the virus that is moving deeper 
into North America and how 
different sectors in the U.S. are 
mobilizing to stem the spread 
of the virus and limit its serious 
side effects.  The panelists were 
L&HCP professors Leslie Meltzer 
Henry and Michael Greenberger, 
University of Maryland School 
of Medicine faculty members Jon 
Mark Hirshon and Kathleen Neuzil 
and the Ambassador from Costa 
Rica to the United States, the 
Honorable Román Macaya Hayes. 
The Zika virus hit South and 
Central America hard in 2016 
causing those countries to develop 
expertise in pandemic response 
earlier than countries in North 
America.  As Zika moves northward 
and becomes endemic in U.S. 
communities, how the US addresses 
the virus will be greatly informed 
by the experience of countries in 
Latin American where the virus first 
emerged.  To that end, the L&HCP 
was honored to have the Ambassador 
from Costa Rica to the U.S., Dr. Román 
Macaya Hayes, open the symposium 
and share Costa Rica’s experience with 
the virus.
The Ambassador was a perfect 
spokesman for Costa Rica’s pandemic 
response efforts because, in addition 
to being a diplomat, he is a chemist 
and biochemist by training and 
Symposium panelists with Ambassador Román Macaya Hayes (fourth from left) 
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has led R&D teams in the fields 
of biotechnology and biomedical 
research in the past.  Ambassador 
Macaya described the country’s 
immediate and targeted approach to 
surveillance, detection and treatment 
when Zika was first identified in the 
country.  Because Costa Rica has a 
nearly universal health care system, 
public health authorities were able to 
quickly identify and treat individuals 
who came down with the virus.  Those 
individuals were monitored closely 
and treated.  Education campaigns 
were initiated early in the emergence 
of the virus and were particularly 
directed to pregnant women given the 
risk of the disease to unborn children 
and the potential for serious congenital 
malformations such as microcephaly.  
In addition, all pregnant women who 
needed them were given window 
and door screens by the government 
to prevent mosquitos entering their 
homes.  Now that the virus has waned, 
the Ambassador reported that only 
two infants have been born with 
microcephaly linked to the virus.  
Participants at the conference were 
particularly struck by the value of a 
public health system and a unified 
medical record system to quickly 
address a pandemic illness.
A number of University of Maryland 
Baltimore faculty members are using 
their expertise to develop and refine 
the legal, medical and regulatory 
tools needed to face a new epidemic.  
Dr. Jon Mark Hirshon, a Professor 
in the Department of Emergency 
Medicine and in the Department of 
Epidemiology and Public Health at 
the University of Maryland School 
of Medicine, described the clinical 
and epidemiological characteristics of 
the Zika virus.  Dr. Hirshon recently 
published “Zika Virus: Critical 
Information for Emergency Providers” 
with colleagues and, as a Board 
Member of the American College of 
Emergency Physicians, is working on 
the organization’s guidelines for the 
virus.  Dr. Hirshon described how, for 
most people, Zika is not harmful but, 
as noted above, can cause damage to 
infants in utero.  How Zika will spread 
through the US is likely to be similar 
to the spread of West Nile virus which 
is in the same flaviviridae family of 
mosquito-bourne arboviruses.  He 
described how the West Nile virus has, 
in some ways, prepared us to respond 
to the Zika virus.
Dr. Kathleen Neuzil, Director of the 
Center for Vaccine Development 
(CVD) at University of Maryland 
School of Medicine, explained that 
CVD was chosen as one of three 
National Institute for Allergy and 
Infectious Diseases (NIAID) study 
sites for a human safety trial of a 
new Zika vaccine. The early-stage 
study will evaluate the experimental 
vaccine's safety and ability to generate 
an immune system response in 
participants.  Neuzil explained that 
existing vaccines for other flaviviruses 
serve as models for a possible 
Zika vaccine.  Several vaccines are 
under investigation.  Two Phase 1 
trials of DNA-based vaccines are 
underway.  A Phase 1 study of a Zika 
purified inactivated virion will start 
soon – this is a vaccine similar to 
vaccines licensed for the Japanese 
encephalitis virus.  Finally, a live 
attenuated vaccine (LAV)  is under 
development but not in trials yet.  An 
LAV is currently available for Dengue 
fever, which is similar to Zika.  In 
sum, there are a number of possible 
vaccine approaches in the preclinical 
and clinical study stage, but nothing 
likely to be available in the next 
few years.  On another note, Neuzil 
noted that a vaccine designed to treat 
sexual and intrauterine infection must 
be safe in children.  She explained 
that the childhood measles-mumps-
rubella vaccine ended the 1964-65 
U.S. rubella epidemic that, prior to the 
vaccine, caused 11,000 miscarriages, 
2100 newborn deaths, 20,000 
babies born with congenital rubella 
syndrome.
L&HCP Professor Leslie Meltzer 
Henry, who is on the faculty at MD 
Carey Law and a core faculty member 
at the Johns Hopkins Berman Institute 
L&HCP Director Diane Hoffmann and Professor Leslie Meltzer Henry
(from left to right)
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of Bioethics, spoke next about the 
Zika virus and women of reproductive 
age.  In the last several years, 
Professor Henry has been working 
intensively as a co-investigator with 
faculty at the Berman Institute on two 
projects relating to the ethical conduct 
of medical research.  One project, 
called PHASES (Pregnancy & HIV/
AIDS: Seeking Equitable Study), is 
looking at conducting research about 
HIV treatment and prevention during 
pregnancy and the other is a Wellcome 
Trust project to develop ethical and 
legal guidance for conducting research 
with pregnant women during public 
health emergencies, like the Zika 
crisis, where there is an urgent need to 
attend to the health needs of pregnant 
women and their offspring.
In her presentation at the Zika 
symposium, Meltzer compared 
the advice given by public health 
officials in Latin America to women 
of reproductive age versus the lived 
reality of these women.  In particular, 
many public health officials have 
recommended women delay pregnancy 
for long periods of time to avoid 
exposing unborn children to the virus.  
However, in Latin America, where 
52% of pregnancies are unplanned 
and access to contraceptives may be 
limited, delaying pregnancy is not 
an option for many women.  She 
also discussed a critical problem in 
vaccine research – reluctance to enroll 
pregnant women in clinical trials 
even when the vaccine is generally 
considered safe or when the vaccine 
could prevent a disease that causes 
harm to pregnant women or their 
babies.  Henry argued that additional 
research is necessary to determine 
what research requires participation of 
pregnant women and what the barriers 
are to conducting such research in 
certain target countries.
Rounding out the discussion, Professor 
Michael Greenberger, a professor at 
Maryland Carey Law and Director of 
the University of Maryland Center 
for Health and Homeland Security 
(CHHS) (see story, p. 1) spoke about 
the law surrounding public health 
emergencies, particularly disease 
surveillance, quarantine and isolation.  
Having served as an expert advisor to 
governments during prior epidemics 
(notably Ebola and H1N1), Professor 
Greenberger shared his conclusion that 
the most effective way to mobilize 
American municipalities and citizens 
during an epidemic is education and 
leadership rather than the force of law.  
Whereas Ambassador Macaya stated 
that, if a safe Zika vaccine become 
available, it would be required in 
Costa Rica, Greenberger noted that 
such an approach would not work in 
the U.S. where coercion is not the 
most effective way to mobilize the 
population.  
Panelist Dr. Jon Mark Hirshon 
Dr. Jody Olsen (second from left), Co-Director of the 
UMB Center for Global Education Initiatives, poses 
with symposium guests
Law & Health Care Program
Spring Newsletter 2017 Pg 13 
Maryland Carey Law Wins First Place in Sixth Annual Health 
Law Regulatory and Compliance Competition
More than 30 students from 11 law schools competed 
in the Sixth Annual Health Law 
Regulatory and Compliance 
Competition on Saturday, March 
4, founded and hosted by the law 
school’s Law and Health Care 
Program. The team from Maryland 
Carey law took first place honors 
with New York University Law 
School placing 2nd and Georgia 
State Law School placing 3rd. 
Working in teams of two or three, 
the students had 90 minutes to 
analyze a hypothetical fact pattern 
which they were reading for the 
first time and then present findings 
and recommendations to a panel 
of practicing regulatory and 
compliance attorneys.  Thirty-three 
lawyers from FDA, HHS, and the 
nation’s most prominent health and 
life sciences law firms participated 
as judges. 
MD Carey Law students Danielle Smith, Ishan Dasgupta, and Mike Pardoe with coach Samantha Collado ’16 
(coach Alexandria Montanio ’15 is not pictured) 
This year’s competition focused 
on the FDA drug approval process 
and bioethical research issues. In 
previous years, the focus has been 
on healthcare fraud and abuse, 
hospitals, payers, the challenges 
associated with new clinically 
integrated care models and 
FDA-regulated clinical trials and 
associated compliance issues.
“We are extremely proud of our 
MD Carey Law students’ victory 
this year,” said Professor Diane 
Hoffmann, longtime director of 
the school’s nationally ranked 
Law and Health Care Program. 
“But given the rigor of this 
competition, all the student teams 
demonstrated a winning mastery 
of incredibly complex legal and 
regulatory issues. The competition 
is a terrific opportunity for 
law students to gain hands-on 
experience and superb insights 
from seasoned professionals. 
We’re thrilled at the Competition’s 
growth. Teams are coming from 
as far away as the west coast to 
compete.”
After the competition, James 
Valentine ’14, an associate at 
Hyman, Phelps &McNamara 
and original organizer of the 
Competition, provided the 
gathered competitors and judges 
with a history of the Competition 
and an explanation of why he 
and Abraham Gitterman ’13, 
an associate in the FDA and 
Healthcare Practice Group at 
Arnold & Porter, worked with 
Hoffmann to create the event in 
2012.
To conclude the award ceremony, 








(Organizer) & Serra 
Schlanger(Judge) 
(from left to right)
Director of the Food and Drug 
Law Institute (FDLI) addressed the 
participants during the celebration 
luncheon sponsored by Baker 
Donelson. Ms. Rick spoke to the 
skill level of the law students in 
the competition and the value 
these young attorneys will bring 
to the critically important field 
of health care compliance.  She 
described how her experience at 
FDLI and in prior positions as the 
Chief Executive Officer of the 
Parkinson’s Action Network (PAN) 
and President of the Coalition 
for the Advancement of Medical 
Research helped her understand 
the critical role that attorneys can 
play in developing and shaping the 
structure of the health care system. 
Ms. Rick also announced the prizes 
that FDLI would present to the 
winners of the competition.
The competition was supported 
by Baker Donelson, Arnold & 
Porter, Hyman, Phelps, McNamara, 
Nelson Mullins, and the American 
Health Lawyers Association.
Georgia State University College of Law Team
New York University School of Law Team
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2017 Stuart Rome Lecture:
Appification to Artificial Intelligence 
and Healthcare’s New Iron Triangle
Professor Nicolas Terry
On April 6, Professor Nicolas P. Terry, Hall Render Professor of Law and Executive Director of the 
William S. and Christine S. Hall Center for Law and Health 
at Indiana University Robert H. McKinney School of Law 
presented the annual Stuart Rome Lecture at University of 
Maryland Carey School of Law.  The talk, “Appification 
to AI and Healthcare’s New Iron Triangle,” focused on 
the intricacy of the impact that advanced information 
technologies will have on healthcare stakeholders in the 
future.  He predicted that the use of these technologies in 
health care will grow on several fronts including the use of 
patient-facing technologies such as medical apps and also 
next generation technologies such as robotics and artificial 
intelligence (AI).  Professor Terry noted that “health care 
policy choices in this ‘second machine age’ will possess a 
degree of complexity that will no longer be reducible (if 
they ever were) to policy binaries.”  He urged the audience, 
particularly, students of health law and policy, to consider 
how this level of complexity will impact the foundational 
approach to discussing health care law and policy – the 
“iron triangle” of access, quality, and cost containment.  
In his lecture, Terry suggested that in the near future, a 
more appropriate way to consider competing priorities in 
the health care system would be a triangle of automation, 
quality/safety and empathy.  
A link to the Rome Lecture is http://www.law.umaryland.
edu/rome2017. 
The Stuart Rome Lecture was established by his family 
and friends to celebrate Stuart Rome’s life and work as an 
attorney, community activist, art patron and humanitarian, 
and is supported by the Stuart Rome Lecture Fund.
Professor Terry’s talk preceded an invitation-only meeting 
on April 7 Medical Automation & Robotics Law & Policy 
Roundtable hosted by L&HCP Professor Frank Pasquale.   
The roundtable, which will be described in greater detail in 
the next newsletter, focused on such critical questions as: 
• What are best practices for assuring privacy and 
data security when innovations like cloud robotics 
could lead to constant real-time monitoring of 
patients?
• Are robotically-assisted surgeons attaining better 
outcomes yet? Are factors like recovery time and 
surgeon satisfaction adequately accounted for in 
outcomes measures? Could policy change better 
optimize the use of robotics in surgery? and
• What is the potential for data-driven health care to 
curb or exacerbate health disparities?
500 West Baltimore Street
Baltimore, MD 21201
www.law.umaryland.edu/healthlaw
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LEGAL RESOURCE CENTER CELEBRATES 15 YEARS OF SERVICE
The Legal Resource Center for Public Health Policy (LRC) at the 
University of Maryland Carey School of Law was established in 
2001 to provide pro bono technical legal assistance on a wide-
range of public health issues, including tobacco regulation, injury 
prevention, to state and local governments, legislators, community 
organizations, health advocacy groups, and Maryland residents.  
Directed by L&HCP faculty member Kathleen Hoke, the LRC is a 
grant-funded legal center that receives primary support from the 
U.S. Centers for Disease Control and Prevention and the Maryland 
Department of Health and Mental Hygiene (DHMH). In addition, 
LRC works closely with state agencies such as the Office of the 
Comptroller and the Office of the Attorney General, as well as 
members of the Maryland General Assembly.  In its 15 years of service, the LRC has served as 
an expert resource center on tobacco control. On May 11, the LRC and DHMH are sponsoring a 
conference called Navigating the Changing Landscape: The Future of Tobacco Control in Maryland.  
The conference will focus on engaging communities around tobacco control, licensing and 
litigation issues, Medicaid coverage for cessation, smoke free housing, and advocacy efforts at the 
state and federal level.  
